Interview with Eduardo Macchiavello, CEO, Roemmers
Roemmers fue establecida en 1921. ¿Cómo paso de ser una empresa familiar a la empresa que es hoy, y cuáles han sido los desafíos en el cambio en la cultura…
The National Administration of Drugs, Foods and Medical Devices (ANMAT) is an agency decentralized from the National Public Administration that was created by decree 1490/92.It cooperates in the protection of human health by assuring the quality of the products it regulates: drugs, foodstuff, medicinal products, diagnosis reagents, cosmetic products, dietary supplements and household cleaning products.Having a nationwide jurisdiction, it was created in August 1992 and ever since its group of professionals and technicians have worked with modern technology in order to efficiently fulfill the process of authorization, registration, standardization, vigilance and monitoring of the products used in the human medicine, food and cosmetic fields.Granted with an economic and financial autarky, in the technical and scientific field it is under the authority of the Ministry of Health Secretariat of Policies, Regulation and Institutes standards and guidelines. In this framework, ANMAT main objective is to guarantee that drugs, foodstuff, medical devices at the reach of the public be compliant in terms of efficacy (fulfillment of the therapeutic, nutritional or diagnostic objective), safety (high benefit/risk ratio) and quality (by meeting the citizens´ needs and expectations).
CONTACT DETAILS
Av. De Mayo 869, C1084AAD – CABA
Tel: +54 (11) 4340-0800
Roemmers fue establecida en 1921. ¿Cómo paso de ser una empresa familiar a la empresa que es hoy, y cuáles han sido los desafíos en el cambio en la cultura…
When we met with Javier Lombar at IMS Argentina, he was explaining how a lot of multinational companies are using Argentina as a regional base of operations. Novartis is a…
The executive management of Nycomed said in an interview that ‘the tremendous growth of the pharmaceutical industry will not occur in either Europe or the United States, but in emerging…
Could you give us an overview of the generics sector in Argentina as it stands at the moment? The generics market in Argentina was started immediately after the regulation regarding…
Do you think this is a good moment for the Argentinean pharmaceutical industry to have international exposure? Indeed it is attractive, but we should keep the long term objectives on…
What have been the recent major milestones for Richmond? One of the milestones for Laboratorios Richmond was to have developed the first branded oncological generic in the world. For Laboratorios…
Biogen Idec’s arrival in Argentina has been very recent. Could you explain to our readers why the time was right to take back your licences and to set up in…
What was the vision behind the creation of the umbrella organisation Amega Biotech in 2005? What led you to consider setting up an organisation with this structure, and offering these…
How has Phoenix developed from being the family company that was founded seventy years ago into the successful corporate business it is today? I joined Phoenix in 1989, at that…
Laboratorios Bernabó es una de las empresas farmacéuticas más distinguidos de toda la historia de la Argentina, con más de 70 años en el mercado. ¿Cómo ha cambiado la visión…
Argentina was home to Roche´s first Latin American subsidiary. Today, how important is Argentina for Roche worldwide? Argentina will become this year the third affiliate –after Brazil and Mexico-in terms…
Novo Nordisk’s largest insulin production facility outside of Denmark is in Latin America, in Brazil. Can you explain the strategic importance of this for Argentina, and how Novo Nordisk is…
See our Cookie Privacy Policy Here
